Obio Technology (Shanghai) Corp., Ltd. (SHA:688238)
China · Delayed Price · Currency is CNY 7.99
-0.08 (-0.99%)
Aug 21, 2025, 4:00 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Cell and Gene Therapy Contract Development and Manufacturing Organization | 134.94M | Log In | Log In | Log In | Log In | Upgrade |
Cell and Gene Therapy Contract Development and Manufacturing Organization Growth | 26.12% | Log In | Log In | Log In | Log In | Upgrade |
Cell and Gene Therapy Contract Research Organization | 85.82M | Log In | Log In | Log In | Log In | Upgrade |
Cell and Gene Therapy Contract Research Organization Growth | 8.02% | Log In | Log In | Log In | Log In | Upgrade |
Biological Agents, Reagents and Others | 23.94M | Log In | Log In | Log In | Log In | Upgrade |
Biological Agents, Reagents and Others Growth | 35.97% | Log In | Log In | Log In | Log In | Upgrade |
Regenerative Medicine Services | 316.96K | Log In | Log In | Log In | Log In | Upgrade |
Other | 3.13M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 312.81% | Log In | Log In | Log In | Log In | Upgrade |
Biomedicine | - | Log In | Log In | Log In | Log In | Upgrade |
IND-CMC service | - | Log In | Log In | Log In | Log In | Upgrade |
IND-CMC service Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Clinical Phase I & II Manufacturing Services | - | Log In | Log In | Log In | Log In | Upgrade |
Pre-IND Supporting Services | - | Log In | Log In | Log In | Log In | Upgrade |
Pre-IND Supporting Services Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Non-IND Services | - | Log In | Log In | Log In | Log In | Upgrade |
Non-IND Services Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
China | 243.40M | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 19.03% | Log In | Log In | Log In | Log In | Upgrade |
Overseas | 1.62M | Log In | Log In | Log In | Log In | Upgrade |
Overseas Growth | 414.41% | Log In | Log In | Log In | Log In | Upgrade |